Skip to main content

Table 2 Univariate associations between comorbidity and ACE inhibitor therapy.

From: Association of angiotensin-converting enzyme inhibitor therapy and comorbidity in diabetes: results from the Vermont diabetes information system

Comorbidity ACE inhibitor non- users
n (%)
ACE inhibitor users
n (%)
Odds Ratio P
Rheumatic disease 80 (14.3) 62 (13.9) 0.97 0.86
Asthma/COPD 116 (20.8) 87 (19.6) 0.93 0.63
CAD 98 (17.6) 95 (21.4) 1.27 0.13
Cancer 82 (14.7) 44 (9.9) 0.64 0.02
CHF 87 (15.6) 85 (19.1) 1.28 0.14
Cirrhosis 9 (1.6) 9 (2.0) 1.26 0.63
CVA 70 (12.5) 48 (10.8) 0.84 0.39
Depression 198 (35.5) 153 (34.4) 0.95 0.72
Paresis 17 (3.1) 13 (2.9) 0.96 0.91
PUD 90 (16.1) 53 (11.9) 0.70 0.06
PVD 45 (8.1) 43 (9.7) 1.22 0.38
  1. N = 1003